These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

634 related items for PubMed ID: 23161752

  • 1. The prognostic value of the metastatic lymph node ratio and maximal metastatic tumor size in pathological N1a papillary thyroid carcinoma.
    Jeon MJ, Yoon JH, Han JM, Yim JH, Hong SJ, Song DE, Ryu JS, Kim TY, Shong YK, Kim WB.
    Eur J Endocrinol; 2013 Feb; 168(2):219-25. PubMed ID: 23161752
    [Abstract] [Full Text] [Related]

  • 2. Lymph node ratio of the central compartment is a significant predictor for locoregional recurrence after prophylactic central neck dissection in patients with thyroid papillary carcinoma.
    Ryu IS, Song CI, Choi SH, Roh JL, Nam SY, Kim SY.
    Ann Surg Oncol; 2014 Jan; 21(1):277-83. PubMed ID: 24006096
    [Abstract] [Full Text] [Related]

  • 3. Recent Changes in the Clinical Outcome of Papillary Thyroid Carcinoma With Cervical Lymph Node Metastasis.
    Jeon MJ, Kim WG, Choi YM, Kwon H, Song DE, Lee YM, Sung TY, Yoon JH, Hong SJ, Baek JH, Lee JH, Ryu JS, Kim TY, Shong YK, Chung KW, Kim WB.
    J Clin Endocrinol Metab; 2015 Sep; 100(9):3470-7. PubMed ID: 26120792
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Risk factors for recurrence of papillary thyroid carcinoma with clinically node-positive lateral neck.
    Lee CW, Roh JL, Gong G, Cho KJ, Choi SH, Nam SY, Kim SY.
    Ann Surg Oncol; 2015 Jan; 22(1):117-24. PubMed ID: 25034816
    [Abstract] [Full Text] [Related]

  • 8. Central lymph node metastasis in papillary thyroid microcarcinoma can be stratified according to the number, the size of metastatic foci, and the presence of desmoplasia.
    Cho SY, Lee TH, Ku YH, Kim HI, Lee GH, Kim MJ.
    Surgery; 2015 Jan; 157(1):111-8. PubMed ID: 25444224
    [Abstract] [Full Text] [Related]

  • 9. Clinical risk factors associated with cervical lymph node recurrence in papillary thyroid carcinoma.
    Baek SK, Jung KY, Kang SM, Kwon SY, Woo JS, Cho SH, Chung EJ.
    Thyroid; 2010 Feb; 20(2):147-52. PubMed ID: 19785522
    [Abstract] [Full Text] [Related]

  • 10. Correlation of minimal extrathyroidal extension with pathologic features of lymph node metastasis in patients with papillary thyroid carcinoma.
    Lee HS, Park C, Kim SW, Park T, Chun BK, Hong JC, Lee KD.
    J Surg Oncol; 2015 Nov; 112(6):592-6. PubMed ID: 26421594
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Risk Factors for Lateral Neck Recurrence of N0/N1a Papillary Thyroid Cancer.
    Kim Y, Roh JL, Gong G, Cho KJ, Choi SH, Nam SY, Kim SY.
    Ann Surg Oncol; 2017 Nov; 24(12):3609-3616. PubMed ID: 28822118
    [Abstract] [Full Text] [Related]

  • 14. Identifying risk factors for recurrence of papillary thyroid cancer in patients who underwent modified radical neck dissection.
    Ryu YJ, Cho JS, Yoon JH, Park MH.
    World J Surg Oncol; 2018 Oct 12; 16(1):205. PubMed ID: 30314503
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.